Medetomidine Infiltrates the US Illicit Opioid Market
JAMA · 05.11.2024 · 332 (17) · 1425
DOI: 10.1001/jama.2024.15992 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 05.11.2024. Verfasst von Joseph J Palamar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health, NYU Grossman School of Medicine, New York, New York. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.
Abstract (Originalsprache)
This Viewpoint discusses the spread of medetomidine in the US illicit opioid market and the need for monitoring and a public health response.
Autor:innen und Institutionen
- Department of Population Health, NYU Grossman School of Medicine, New York, New York.
- Center for Forensic Science Research and Education, Fredric Rieders Family Foundation, Horsham, Pennsylvania.
- College of Life Sciences, Thomas Jefferson University, Philadelphia, Pennsylvania.
Förderung
- NIDA NIH HHS
Zitieren
APA
Palamar, J. J., & Krotulski, A. J. (2024). Medetomidine Infiltrates the US Illicit Opioid Market. JAMA, 332(17), 1425. https://doi.org/10.1001/jama.2024.15992
Vancouver
Palamar JJ, Krotulski AJ. Medetomidine Infiltrates the US Illicit Opioid Market. JAMA. 2024;332(17):1425. doi:10.1001/jama.2024.15992
BibTeX
@article{Palamar2024,
author = {Palamar, Joseph J and Krotulski, Alex J},
title = {Medetomidine Infiltrates the US Illicit Opioid Market},
journal = {JAMA},
year = {2024},
volume = {332},
number = {17},
pages = {1425},
doi = {10.1001/jama.2024.15992}
}
EUVIMED